Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons

被引:7
|
作者
Monamele, Chavely Gwladys [1 ,2 ]
Njifon, Hermann Landry Munshili [3 ,4 ]
Vernet, Marie-Astrid [1 ]
Njankouo, Mohamadou Ripa [1 ]
Kenmoe, Sebastien [1 ]
Yahaya, Ali Ahmed [5 ]
Deweerdt, Louis [3 ]
Nono, Raphael [3 ]
Mbacham, Wilfred [4 ]
Anong, Damian Nota [2 ]
Akoachere, Jane Francis [2 ]
Njouom, Richard [1 ]
机构
[1] Ctr Pasteur Cameroon, Natl Influenza Ctr, Yaounde, Cameroon
[2] Univ Buea, Buea, Cameroon
[3] Ctr Pasteur Cameroon, Annex Of Garoua, Garoua, Cameroon
[4] Univ Yaounde I, Yaounde, Cameroon
[5] WHO, Reg Off Africa, Brazzaville, Rep Congo
来源
PLOS ONE | 2019年 / 14卷 / 01期
关键词
GENETIC-CHARACTERIZATION; VIRUSES; HEMAGGLUTININ; EPIDEMIOLOGY; A(H3N2); H1N1;
D O I
10.1371/journal.pone.0210119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In 2009, Influenza A(H1N1)pdm09 caused the first influenza pandemic of the 21st century with high mortality rates of about 284 500 deaths. This virus, however, continues to circulate as a seasonal influenza virus and to cause illness and deaths worldwide. In this study, we describe the genetic diversity of A(H1N1)pdm09 viruses collected between 2014 and 2016 in Cameroon. Three gene segments (HA, NA and M) of Cameroon strains were studied. The phylogenetic tree of the coding nucleotide sequences was generated by MEGA version 6.0 using a Maximum Likelihood method. The NA and M protein coding sequences were analyzed for the reported genetic markers of resistance against neuraminidase inhibitors and adamantanes, while predicted vaccine efficacy was estimated using the P-epitope method. Overall 39 strains were obtained. Phylogenetic analysis of the HA gene of influenza A(H1N1)pdm09 showed that Cameroon strains belonged to two major clades. The 2014 Cameroon sequences belonged to clade 6C while all sequences collected between 2015 and 2016 belonged to clade 6B. Majority of the samples had some mutations in the NA gene notably: I117M, N248D, and N369K while the amantadine-resistant M mutant, S31N, was found to be absent only in the two sequences collected in 2014. Overall, A/California/07/2009 vaccine strain showed a predicted vaccine efficacy of 24.55% to 35.77% against Cameroon A(H1N1)pdm09 strains circulating between 2014 and 2016. Our findings confirms the fast evolution of A(H1N1)pdm09 since its first introduction and highlights on the importance of influenza vaccine in reducing the burden caused by influenza in the community.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Genetic and potential antigenic evolution of influenza A(H1N1)pdm09 viruses circulating in Kenya during 2009–2018 influenza seasons
    D. Collins Owuor
    Zaydah R. de Laurent
    Bryan O. Nyawanda
    Gideon O. Emukule
    Rebecca Kondor
    John R. Barnes
    D. James Nokes
    Charles N. Agoti
    Sandra S. Chaves
    Scientific Reports, 13
  • [22] Evolution of the Hemagglutinin Gene of the Influenza A(H1N1)pdm09 Virus in Morocco During Two Influenza Seasons 2009-2011
    El Rhaffouli, Hicham
    El Fahime, El Mostafa
    Laraqui, Abdellilah
    Bajjou, Tahar
    Melloul, Marouane
    Obeid, Susan
    Fathallah, Lahoussine
    Lahlou-Amine, Idriss
    CURRENT MICROBIOLOGY, 2014, 68 (03) : 372 - 380
  • [23] Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
    Simon, Marie
    Hernu, Romain
    Cour, Martin
    Casalegno, Jean-Sebastien
    Lina, Bruno
    Argaud, Laurent
    EMERGING INFECTIOUS DISEASES, 2013, 19 (06) : 1005 - 1007
  • [24] Influenza A(H1N1)pdm09 virus in pigs, Togo, 2013
    Ducatez, Mariette F.
    Awoume, Felix
    Webby, Richard J.
    VETERINARY MICROBIOLOGY, 2015, 177 (1-2) : 201 - 205
  • [25] Outcomes of infants born to women with influenza A(H1N1)pdm09
    Newsome, Kim
    Alverson, C. J.
    Williams, Jennifer
    McIntyre, Anne F.
    Fine, Anne D.
    Wasserman, Cathy
    Lofy, Kathryn H.
    Acosta, Meileen
    Louie, Janice K.
    Jones-Vessey, Kathleen
    Stanfield, Valoree
    Yeung, Alice
    Rasmussen, Sonja A.
    BIRTH DEFECTS RESEARCH, 2019, 111 (02): : 88 - 95
  • [26] Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe
    Mereckiene, J.
    Cotter, S.
    Weber, J. T.
    Nicoll, A.
    D'Ancona, F.
    Lopalco, P. L.
    Johansen, K.
    Wasley, A. M.
    Jorgensen, P.
    Levy-Bruhl, D.
    Giambi, C.
    Stefanoff, P.
    Dematte, L.
    O'Flanagan, D.
    EUROSURVEILLANCE, 2012, 17 (04) : 18 - 27
  • [27] Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation
    Ge, Pan
    Ross, Ted M.
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 519 - 526
  • [28] Fetal Safety of an Adjuvanted Influenza A(H1N1)pdm09 Vaccine
    Molgaard-Nielsen, Ditte
    Pasternak, Bjorn
    Svanstrom, Henrik
    Krause, Tyra G.
    Emborg, Hanne-Dorthe
    Melbye, Mads
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 392 - 392
  • [29] Molecular diagnosis of microbial copathogens with influenza A(H1N1)pdm09 in Oaxaca, Mexico
    Romn Ramirez-Palacios, Luis
    Resendez-Perez, Diana
    Cristina Rodriguez-Padilla, Maria
    Saavedra-Alonso, Santiago
    Real-Najarro, Olga
    Fernandez-Santos, Nadia A.
    Rodriguez Perez, Mario A.
    RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2018, 9 : 49 - 62
  • [30] Influenza A(H1N1) pdm09 Virus in Pigs, Reunion Island
    Cardinale, Eric
    Pascalis, Herve
    Temmam, Sarah
    Herve, Severine
    Saulnier, Aure
    Turpin, Magali
    Barbier, Nicolas
    Hoarau, Johny
    Queguiner, Stephane
    Gorin, Stephane
    Foray, Coralie
    Roger, Matthieu
    Porphyre, Vincent
    Andre, Paul
    Thomas, Thierry
    de Lamballerie, Xavier
    Dellagi, Koussay
    Simon, Gaelle
    EMERGING INFECTIOUS DISEASES, 2012, 18 (10) : 1665 - 1668